A Disodium phosphate, anhydrous CEP of the European Pharmacopoeia monograph is often referred to as a Disodium phosphate, anhydrous Certificate of Suitability (COS). The purpose of a Disodium phosphate, anhydrous CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Disodium phosphate, anhydrous EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Disodium phosphate, anhydrous to their clients by showing that a Disodium phosphate, anhydrous CEP has been issued for it. The manufacturer submits a Disodium phosphate, anhydrous CEP (COS) as part of the market authorization procedure, and it takes on the role of a Disodium phosphate, anhydrous CEP holder for the record. Additionally, the data presented in the Disodium phosphate, anhydrous CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Disodium phosphate, anhydrous DMF.
A Disodium phosphate, anhydrous CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Disodium phosphate, anhydrous CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Disodium phosphate, anhydrous suppliers with CEP (COS) on PharmaCompass.